Verfasser: |
Westgeest, H. M.
Kuppen, M.
van den Eertwegh, A. J.M.
Van Moorselaar, J.
Mehra, N.
van Oort, I.
van den Bergh, A. C.M.
Coenen, J. L.
Aben, K. K.H.
Somford, R.
de Wit, R.
Bergman, A.
Lavalaye, J.
Uyl-de Groot, C. A.
Gerritsen, W. R. |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2018 |
Reihe/Periodikum: |
Westgeest , H M , Kuppen , M , van den Eertwegh , A J M , Van Moorselaar , J , Mehra , N , van Oort , I , van den Bergh , A C M , Coenen , J L , Aben , K K H , Somford , R , de Wit , R , Bergman , A , Lavalaye , J , Uyl-de Groot , C A & Gerritsen , W R 2018 , ' Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI : An observational study in the Netherlands ' , Annals of oncology : official journal of the European Society for Medical Oncology , vol. 29 , pp. viii283-viii284 . https://doi.org/10.1093/annonc/mdy284.026 |
Sprache: |
Englisch |
Permalink: |
https://search.fid-benelux.de/Record/base-28802681 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://research.vumc.nl/en/publications/3541a914-b06c-4330-9d4f-f3fc6ee2dee8 |